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ABSTRACT
Objective   
To determine if obese patients have longer average length of stay once they are admitted to 
hospital, across a range of specialties.  This contributes to measuring the impact of obesity on 
health care resource use. 
Data Sources/Study Setting   
Administrative hospital data are used for the financial year 2005/06 covering all episodes of 
patient care (1.3 million) in 122 public hospitals in the state of Victoria, Australia.  The data are 
collected as part of Diagnosis Related Group (DRG) case mix funding arrangements by the state 
government.  
Study Design  
Statistical analysis are undertaken using quantile regression analysis to determine differences in 
average length of stay within different specialties for two groups of patients, those classified as 
obese, and those not classified as obese.  Quantile regression allows a comparison of 
differences between the length of stay of obese and non-obese patients across the whole 
distribution of length of stay of inpatients, in contrast to more commonly used statistical methods 
which use only the mean.  We condition on a range of patient and hospital characteristics such as 
age, sex, socioeconomic status, medical complexity of patients, teaching status, size and location 
of hospitals.   
Data Collection/Extraction Methods  
Data on inpatient episodes with at least one overnight stay in hospital are used.  We exclude 
episodes with missing information on one or more of the explanatory variables and we exclude 
specialties with less than 50 reported obese inpatients per financial year.  The final sample 
consists of just over 460,000 observations.  
Principal Findings  
Large and significant differences in average length of stay are found between obese and non-
obese patients for nearly all specialties.  In some specialties, obese patients can stay up to 4 
days longer.  However, obesity does not necessarily lead to longer hospital stays.  In a range of 
specialties, obese patients have shorter length of stay on average.  In general, differences 
between obese and non-obese patients are more pronounced at greater levels of medical 
complexity.  There is some evidence that differences may arise because obese patients are more 
likely to be treated medically rather than surgically, to be transferred to another hospital, thus 
shifting risks and costs, or to die from higher complication rates.   
Conclusions   
Our study sheds new light on the impact of obesity on health care costs.  We demonstrate that an 
analysis across the whole spectrum of medical complexity provides much better estimates of 
resource use by obese patients than standard techniques.  Future research should focus on 
differences in the way obese patients are managed in hospital.  This will show where resource 
use is most intense, and help policy makers and hospital managers increase efficiency and 
quality of care for obese patients.   
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Do obese patients stay longer in hospital? 
Estimating the health care costs of obesity
1. Introduction 
Increasing obesity rates are a major public health concern in many countries, as the obese have 
significantly higher risks of developing serious illnesses such as type II diabetes, cardiovascular 
disease, osteoarthritis, and various cancers.  Financial costs are high.  In Europe and the USA 
costs of obesity have been estimated at over 6% of health care spending (Bolin and Cawley, 
2007), which conservatively translates to US$120 billion annually in the USA alone.  There are 
great variations in cost estimates, both within and between countries.  For example, in the USA 
costs are estimated to lie between 4-8% of health spending (Allison et al, 1999, Colditz, 1999; 
Kortt et al, 1998), in Canada, costs have been estimated at up to 5% of health expenditure 
(CN$3.5-4 billion), (Birmingham et al, 1999; Katzmarzyk and Janssen, 2004).  For France costs 
are estimated at 1.5-2.5% of health expenditure (Detournay, 2000; Levy et al 1995), and for New 
Zealand a figure of 2.5% has been estimated (Swinburn et al, 1997).  A substantial portion of 
obesity costs are direct financial costs to the health care system.  For example, of total costs 
estimated at A$3.7 billion in Australia, direct costs make up A$870 million, or almost one quarter 
(Access Economics, 2006).  
Differences in estimates are partly due to differing prevalence rates across countries (Bleich, 
2007), differing actual costs of treatment, and differing methodologies on which cost studies are 
based.  Commonly, researchers identify a number of co-morbidities of obesity, and then estimate 
the extent to which each co-morbidity (and cost) is attributable to obesity.  It is difficult to generate 
correct estimates of these ‘population attributable fractions’ (PAFs), because they depend on the 
accuracy of the measure of relative risk made use of.  There are wide variations in estimates of 
relative risks of diseases, again, both within and between countries.  This is a particular problem 
for obesity, in terms of interactions between risk factors (Mark, 2005).  PAFs may systematically 
underestimate the economic cost of obesity because they neglect costs of treating illnesses not 
directly caused, but aggravated by obesity.  Obesity may influence the progression or severity of 
many conditions, such as type II diabetes, hypertension, hypercholesterolemia, osteoarthritis, 
gallbladder disease, and some cancers (Muennig et al, 2006; Busija et al, 2007).  This would 
imply that for a large variety of conditions, obese patients are more expensive to treat than non-
obese patients.  Overall, surprisingly little is known about the use of hospital resources by obese 
patients (Folmann et al, 2007; Shafer and Ferraro, 2007), especially when controlling for medical 
complexity.   
In order to test the hypothesis that the obese use more resources, we estimate the differences in 
length of stay for public hospital admissions between obese and non-obese inpatients, conditional 
on explanatory factors, using Diagnosis Related Group (DRG) based utilization data, and 
controlling for medical complexity.  We use data for inpatient episodes – covering 460,000 
observations.  The data contain rich information on patient and hospital characteristics, including 
whether a patient is classified as obese.  We use quantile regression techniques to estimate the 
differences in length of stay (LOS) over the whole distribution for patients from various 
specialties, and for medical and surgical patients.  LOS is a major determinant of hospital costs, 
and it gives a tractable measure of hospital resource use in management terms.  Use of quantile 
regression techniques provides us with several estimates of differences in LOS over the whole 
range of patient medical complexity, and is therefore superior to standard techniques which 
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generate only one estimate at the mean level of complexity.  This provides hospital managers 
and policy makers with valuable extra information.   
2. Data 
We use the Victorian Admitted Episodes Data (VAED) for inpatients above 5 years of age in 
public hospitals in the state of Victoria, Australia, for 2005/06.  The VAED are administrative 
hospital data for all public hospitals, and they are generally of high quality because hospitals have 
a strong financial incentive to generate detailed records of all their patients, as they receive the 
largest part of their budget via DRG based casemix funding.  This type of funding was introduced 
in Victoria in 1993/94, so hospital administrators are experienced in collecting and processing 
patient level data.   
Our sample consists of 461,563 inpatients in 17 specialties.  We exclude specialties which 
predominantly treat day cases (patients with no overnight stay) and/or report only a small number 
of obese inpatients per financial year, because results from such a sample would not be robust.  
For the included specialties, the average number of reported obese patients is 357 (those 
excluded are Ophthalmology, Dental Surgery, Oncology/Radiology, Psychiatry and Renal 
Dialysis).  Within the remaining specialties, we exclude patients treated as day cases and with 
missing values on one or more of the explanatory variables.  Table 2 reports the frequencies and 
percentages of obese patients per specialty.  Each data record contains one patient episode 
which starts with the patient’s admission to a hospital department and ends with the patient’s 
discharge from that department.  Table 1 shows all variables used in the estimation, with the 
dependent variable being a patient’s length of stay (LOS) per episode, in days.  A patient’s total 
stay in hospital may be longer.  If a patient is referred to another hospital, or even another 
department in the same hospital, this is recorded as a new episode.  The way a patient is 
managed in hospital is likely to affect LOS, and therefore, we control for this as far as possible.  
We cannot link several episodes, but we try to take account of transfers by including information 
on the origin of patients at admission, and their destination at discharge.  The variables transadmi 
and transep indicate whether a patient is admitted/discharged from/to another hospital, acute 
care centre, other department within the same hospital, or community based mental or aged care 
centre.  We also distinguish whether a patient is discharged home or leaves against medical 
advice (home), or dies in hospital (death).  We include a patient’s type of admission, either as an 
emergency case (nonelect), from a waiting list (elect), or in another way (othadmtype), which 
covers mainly maternity or newborn patients.   
We include four variables of medical complexity.  Numberdiag and numberop are two discrete 
variables counting, respectively, the number of diagnoses and procedures undertaken on the 
patient, with the assumption that higher values of one or both variables characterize more 
complex patients.  We also include a variable comp to indicate whether a patient experienced a 
medical complication.  We define a medical complication based on (a) a set of specific 
international classification of disease (ICD) codes which - by definition - identify patients with a 
medical complication or adverse event before or during the episode and (b) a C-prefix to ICD 
diagnosis codes which identify patients who suffered a complication during the episode (we adopt 
the definition of medical complication as described in Jackson et al. 2006).  This prefix is a unique 
feature of the VAED.  As a fourth control for medical complexity, we use the cost weight of the 
patient episode (w12wies) which is derived from patient cost information and forms the basis for 
hospital reimbursement under the state casemix funding system.   
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We include several variables on patient characteristics to control for differences in medical need:  
female controls for gender differences, and age and age2 take account of potential nonlinear 
relationships between age and LOS.  We use two (crude) measures of a patient’s socioeconomic 
status.  First, we include information on whether a patient paid privately for the admission 
(private) as a marker for income.  In Australia, the majority of private payments are reimbursed by 
private health insurance funds.  Around half of the population has private health insurance, and 
take-up is associated with income.  Second, we link the VAED with an index of socio-
demographic deprivation measured at postcode level.  The socioeconomic index of relative 
advantage/disadvantage (seifa) is generated from 2001 census data information on residents’ 
income, occupation, education, and other factors, and measures the relative socioeconomic 
advantage of geographical areas at postcode level.  The index is centered around 1, and 
advantaged/disadvantaged areas are characterized by high/low values (ABS, 2003).   
We also include several variables on hospital characteristics.  Major, city, ruralmed and ruralsmall 
characterize size, teaching status and location of hospitals.  We do not have information on the 
number of beds or staffing levels in the hospitals, but we can include information on the overall 
number of admissions in a year to account for the size of hospitals (totsep).   
Obesity among patients: the ‘false negatives’ problem 
The most important explanatory variable for the purpose of our analysis is whether a patient is 
obese.  We define patients as obese if one of their diagnosis codes (beyond their first diagnosis) 
falls within the range of ICD codes E660 to E669 (conditions related to obesity).  These are 
generic codes for obesity, meaning that patients are coded as obese independently of other 
diagnoses codes or the procedures or surgical activity undertaken on the patient.   
In our sample, 6,086 (1.32%) of inpatients are classified as obese in this way.  This implies that 
obese patients are underrepresented among the patient population - the prevalence of obesity in 
the general population of Victoria is markedly higher at 16% (VPHS, 2002).  This indicates that 
there are a large proportion of false negatives - obese patients incorrectly reported as non-obese 
- in the patient population, which results in an underestimate of the extent of obesity among 
inpatients.  This underreporting is a consequence of basing our classification of ‘obese’ on 
reported ICD codes, but lack of data forces us to adopt this definition.  To get an understanding of 
the extent and possible causes of the ‘false negatives’ problem, we compare the prevalence of 
obesity in patients over different hospital specialties (see table 2).  Recorded obesity varies, with 
highest rates reported for Endocrinology (4.43%) and Cardiology (2.89%).  These are specialties 
for which there may be a relatively big influence of a patient’s weight on treatment choices and 
outcomes.  It is plausible that medical staff are more vigilant in reporting obesity if it is thought to 
impact the patient’s case.  However, hospitals have no financial incentive for recording a patient 
as obese as this would make no difference to the final case-mix reimbursement.  This may 
explain why Obstetrics (0.31%) and Ear, Nose and Throat (ENT) (0.47%) have the lowest rates of 
reported obesity.  In these specialties, conditions that patients present with are similar and 
treatments are comparably standardized, such as in Obstetrics, and/or doctors may (rightly or 
wrongly) suspect that there is little influence of a patient’s weight on final treatment outcomes, 
such as in ENT.   
Random underreporting of obese patients would not create any serious problems in the statistical 
estimation, however, systematic underreporting may.  It could imply that false negative 
(unreported) and true positive (reported) obese patients are managed in different ways.  For 
example, reported obese patients could be more likely to be treated medically than non-reported 
obese patients because of a (perceived) greater risk associated with surgery.  As a justification 
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for the chosen treatment, these medically treated obese patients may be more likely to be 
reported as obese.  On the other hand, obese patients who are treated surgically may be more 
likely to be reported as obese because administration of anesthetics requires the exact reporting 
of the patients’ weight and may alert doctors.  In econometric analysis terms, underreporting can 
be classified as an error-in-variables problem which can be alleviated with instrumental variables 
(IV) techniques (Green 2003).  Instruments need to be correlated with the misreported variable, 
but not with the error term in the statistical model.  As we have only limited information on patient 
characteristics, and these are most likely to influence both obesity and LOS (directly, or indirectly 
over medical complexity), there are no suitable instruments in our data and we cannot employ IV 
techniques.  However, any possible bias arising from underreporting will most likely lead to 
insignificant results.  The estimated differences in LOS between obese and non-obese will err 
towards zero, as the non-obese control group in our sample is ‘contaminated’ with unreported 
obese patients.  This would imply that estimated differences are conservatively low estimates of 
the real differences.  Given all of the above, any systematic underreporting, if it is present in our 
sample, is unlikely to cause misleading results. 
Table 1 shows summary statistics of all variables, by obese and non-obese inpatients.  The 
obese have a longer mean LOS, and they are more likely to be admitted as an emergency case.  
They are, on average, of greater medical complexity, as indicated by their higher average cost 
weight, have nearly double the co-morbidities, greater numbers of procedures undertaken, and 
higher rates of medical complications.  On average, obese inpatients are older, more likely to be 
male, and have a slightly lower socioeconomic profile as indicated by the variables private and 
seifa.  They are more likely to be admitted or discharged by transfer, but the difference is small, 
and they are more likely to be treated in one of the major teaching hospitals.  
3. Methods 
We estimate the following linear model: 
los = f (obese, nonelect, othadmtype, transadmi, transep, death, w12wies, numberdiag, 
numberop, comp, age, age2, female, private, seifa, totsep, major, ruralmed, ruralsmall)  
separately for 17 hospital specialties.  We also estimate the model separately for patients treated 
medically and surgically, across all specialties.  The estimated impact of obesity on LOS is 
provided by the coefficient on the dummy variable obese.  A statistically significant positive 
(negative) coefficient shows the number of days that an obese patient stays longer (shorter) per 
episode than a non-obese patient, on average and conditional on other explanatory factors.   
An analysis of the residuals from an ordinary least squares (OLS) regression on the whole 
sample shows a large proportion of outlying observations, both at the upper and lower ends of the 
distribution.  We adopt a definition of outliers based on the interquartile range, so that an 
observation is defined as a lower outlier if resOLS < Q(25) - 3*Inter Quartile Range, and an upper 
outlier if resOLS > Q(75) + 3*Inter Quartile Range (Tukey 1977).  According to this definition, 3.3% 
of patients have very long stays (upper outliers) and 1.3% very short stays (lower outliers), 
conditional on observable characteristics.  Such a large proportion of outliers is incompatible with 
assumptions of normality imposed by OLS.  A practical approach for dealing with outliers is to 
include a dummy variable among the regressors to indicate outlier status.  However, this would 
effectively eliminate outlying patients from the analysis without providing a causal explanation for 
their outlier status.  Outlying patients may convey valuable information on the relationship 
between obesity and LOS which should not be lost.  Therefore, we adopt a quantile regression 
(QR) model which allows us to incorporate the information provided by outliers, but limits their 
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detrimental effect on the estimation.  The QR model relaxes the OLS assumption that the effect 
of obese is constant along the whole distribution of the dependent variable LOS (Koenker and 
Bassett 1978, Variyam et al. 2002).  Quantiles of the conditional distribution of LOS are 
expressed as functions of observed covariates.  The objective of QR is to estimate the median 
(rather than the mean) of the dependent variable conditional on the values of the independent 
variables.  Thus, QR minimizes a sum of absolute residuals, as opposed to a sum of squared 
residuals.  We use quantile regressions on 19 quantiles of LOS, ranging from 0.05 (very short 
LOS) to 0.95 (very long LOS), and including the median 0.5.   
The residuals are weighted asymmetrically for all quantiles, except the median.  This feature, 
together with estimation of the median, helps to alleviate the outlier problem.  It guarantees that 
the influence of outliers is diminished on estimates generated from midranges and opposite ends 
of the distribution, as residuals at the extreme ends of the distribution are given a lower weight.  
In addition, QR generates different estimates of the impact of obese on LOS across the whole 
distribution of LOS.  This gives us an insight into whether obesity has a larger or smaller effect 
among patients staying a long time in hospitals as opposed to patients staying a shorter time in 
hospital.  Patients with long LOS are usually complex patients with comparably severe medical 
problems, so that, in fact, we are estimating whether the influence of obesity varies across the 
distribution of medical complexity.  STATA 10 (STATA Corporation, 2007) is used for the 
estimations. 
4. Results 
Coefficient Estimates for the Whole Sample 
Table 3 shows coefficient estimates for the model estimated by OLS regression on the whole 
sample.  All coefficient estimates are statistically significant, which is partly explained by the large 
sample size.  We are above all interested in the coefficient on obese, because it indicates 
differences in average length of stay (ALOS) between obese and non-obese patients. Perhaps 
surprisingly, the coefficient is negative, which implies that obese patients stay shorter than non-
obese patients with comparable characteristics.  The coefficient value of -0.4 means that obese 
patients stay on average about half a day shorter than non-obese patients.  We discuss possible 
reasons for this result further down.  With respect to the other explanatory variables, we find that 
there is a strong positive impact of the cost weight w12wies on LOS, indicating that patients of 
higher medical complexity and resource intensity stay longer in hospital.  Increasing the cost 
weight by 1 point increases LOS by about 2.4 days, on average and conditional on other 
explanatory variables.  Being admitted as an emergency or as an ‘other’ type of patient increases 
length of stay by over a day in comparison to being admitted as an elective patient, probably 
indicating greater medical complexity.  Being admitted in a small rural hospital increases LOS by 
1.8 days in comparison to being admitted to a big city hospital.  If the episode ends with the death 
of the patient, we can observe that the episode is on average 1.2 days shorter than the one of a 
comparable patient which does not die.  It may be that the stay of complex patients is cut short by 
their death.  The rest of the variables influence ALOS by less than one day.  We find that ALOS 
decreases with age, but the relation is nonlinear as indicated by the positive coefficient on age2, 
and it decreases with the size of the hospital (totsep).  ALOS is shorter for patients paying 
privately for the hospital stay and living in a socially more advantaged area, indicating that 
patients of higher income and socioeconomic status have lower medical need.  ALOS is slightly 
shorter in a major teaching hospital than in a normal city hospital, which is perhaps surprising 
because teaching hospital tend to treat more complex patients, on average.  The shorter LOS 
may be due to greater efficiency in teaching hospitals.  ALOS increases with the number of 
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diagnosis and procedures undertaken on the patient, and it is higher for patients who suffer a 
complication or are transferred from or to another hospital, all indicating that more complex 
patients have longer ALOS.  Females stay around 0.3 days longer than males.   
Quantile regression (QR) results for the 10th quantile (short staying patient groups of low 
complexity), 50th quantile (patient groups with average lengths of stay) and the 90th quantile 
(patients with long lengths of stay) are presented in tables 4, 5, and 6.  The Median regression 
(50th quantile) is comparably to OLS, and by and large, the OLS estimates are confirmed by the 
QR results.  The exception is the coefficient on obese.  For the 10th and 50th quantile, the 
coefficient is not statistically significant.  For the 90th quantile of long staying patients, the 
coefficient is positive and significant.  It indicates that for medically very complex patients across 
the whole sample, obese patients stay about 0.2 days longer than non-obese patients, on 
average and conditional on other observable factors.   
Estimates on the impact of obesity on specialty level 
Results for the whole sample may be misleading, because it is likely that there are great 
differences between hospital specialties.  Therefore, we estimate our model separately for 17 
specialties.  It is beyond the scope of this working paper to display results for every specialty, 
quantile and coefficient.  We use figures and summary tables to compare the results in a 
manageable way, focusing on the coefficient for obese only.  More detailed results are available 
from the authors on request.   
When estimating the QR and OLS models separately by specialty, we find that being obese has a 
distinctly different influence on LOS according to the specialty treating the patient.  Coefficient 
estimates for the variable obese are displayed in Figures 1 to 19.  A positive (negative) coefficient 
implies that obese have a longer (shorter) average length of stay in hospital than non-obese.  
Plotted are the estimated coefficients and 95% confidence intervals, with increasing LOS towards 
the right side of the diagram.  The OLS (mean) estimate, represented by the triangles is, by 
assumption, constant across the whole distribution of LOS.  The QR coefficients, represented by 
the circles, can be seen to differ across the distribution.   
For General Medicine (figure 1), the OLS coefficient has a statistically significant positive value, 
implying that obese patients experience, on average, around 1.7 days longer in hospital, 
conditional on other explanatory factors.  QR results for General Medicine show that the 
coefficient estimates for obese increase over the distribution of LOS.  This implies that there is no 
or only a small difference in ALOS between obese and non-obese patients for the lower end of 
the distribution, i.e. for shorter LOS or patients of lower medical complexity.  However, obese 
patients start to have significantly longer stays in hospital from around the median LOS, with 
coefficient estimates increasing to nearly 4 days longer ALOS for the 95th quantile of very 
complex and long-staying patients.   
We can observe similar results for eight other hospital specialties.  At the lower end of the 
distribution (shorter LOS), differences between obese and non-obese patients are small or 
statistically insignificant, but at the upper end (longer LOS), obese patients stay significantly 
longer (see figures 1 to 9).  Table 7 provides a summary of the results shown in the figures.  
Reported are the maximum estimated difference in ALOS between obese and non-obese, and 
the percentile of the distribution of LOS at which this result is obtained.  Only statistically 
significant coefficients are considered.  Maximum average differences in LOS are nearly 2 days 
for Plastic Surgery (1.9 days at the 80th quantile), 1.4 days (95th quantile) for Obstetrics, 1.1 days 
for ENT (80th quantile), 1 day (90th quantile) for Orthopedics, 0.9 days (95th quantile) for 
Gynecology, 0.4 days (95th quantile) for Neurology, 0.4 days (75th quantile) for Endocrinology, 
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and 0.2 days at the 75th quantile in General Surgery.  A perfect trend of gradually increasing 
differences between obese and non-obese can only be observed for General Medicine.  For 
Obstetrics, Orthopedics and Gynecology, differences in ALOS between obese and non-obese 
patients are negligible except for the highest quantiles, where there are comparably large 
differences in ALOS.  This implies that the most complex obese patients in these three specialties 
stay longer than the most complex non-obese obstetrics patients, but there is no difference for 
patients at average and low levels of medical complexity.  It is also noteworthy that differences in 
LOS for Plastic Surgery, ENT and Endocrinology peak around the 80th quantile (and not at the 
95th quantile as one might expect) and become smaller again towards the highest quantile.  This 
is most marked for Endocrinology, where differences for the four highest quantiles are 
insignificant.  For ENT and General Surgery there are significant differences in LOS from low 
quantiles onwards - obese patients stay longer than non-obese patients across the whole range 
of complexity with no or only a slight increase.  However, absolute differences in LOS are very 
small for General Surgery.  For Neurology, differences are very small as well, with the only 
significant differences around the 60th quantile and the two highest quantiles.  OLS coefficient 
estimates are significant only for General Medicine and Orthopedics.  The OLS estimate for 
Orthopedics is negative, which may be due to the biasing influence of outliers affecting the OLS 
estimation.  Obstetrics and Endocrinology also have negative OLS coefficients, but neither of 
them is statistically significant.   
In summary, the positive pattern that obese patients stay -on average and at certain quantiles- 
more than one day longer in hospital than non-obese patients can be observed for the specialties 
General Medicine, Plastic Surgery, Obstetrics and ENT.  Obese patients also stay longer in the 
specialties Gynecology, Orthopedics, Neurology, General Surgery and Endocrinology, but the 
maximum differences are less than one day.  For nearly all of the above specialties, differences 
between the obese and non-obese samples tend to increase with LOS in hospital.  The results for 
these specialties confirm our hypothesis that obese patients stay longer in hospital on average 
and are more expensive to treat than non-obese patients with the same observable 
characteristics, in particular similar levels of medical complexity.  Differences tend to increase for 
the longer staying patient groups of greater medical complexity.  This increase is not picked up by 
OLS, because it provides only an average estimate over the distribution of LOS.  Moreover, we 
find that OLS, in comparison to QR, overestimates resource use for short-staying obese patients 
and underestimates it for long-staying obese patients.  In turn estimates of the impact of obesity 
on health care resources by obese patients from the extreme ends of the distribution would be 
markedly different if they relied on the OLS results.   
For eight specialties we find the surprising result that obese patients stay on average shorter than 
non-obese patients, especially patient groups at higher levels of complexity.  Figures 10 to 17 and 
table 7 show results for these specialties with negative patterns.  We can see again that 
differences in ALOS tend to increase over the distribution of LOS up to the quantile of patients 
with high levels of medical complexity, but differences are in the opposite direction so that obese 
patients stay shorter on average than non-obese patients, conditional on observable explanatory 
factors.  For all specialties with negative pattern, the QR results are confirmed by negative OLS 
coefficients, but they are only significant for Vascular, Respiratory, Cardiology, and Nephrology.  
For specialties with the negative pattern, OLS also tends to overestimate (underestimate) the 
difference between obese and non-obese patients for short (long) stays in comparison to QR, 
which would leads to different results on the resource use by obese patients.   
According to the results from the Quantile Regressions, maximum differences in ALOS are -2.4 
days (85th quantile) for Vascular, -1.7 days (95th quantile) for Neurosurgery, -1.5 days (95th 
quantile) for Rheumatology, -1.2 days (90th and 95th quantiles) for Respiratory, -1.1 (95th quantile) 
 Translational research in the area of inequalities in health related to obesity in Australia 8  
for Cardiology, -0.6 days (95th quantile) for Hematology, -0.5 days (95th quantile) for Urology, and 
-0.4 (70th and 75th quantile) for Nephrology.  We observe a near perfect trend line with gradually 
increasing differences over the whole distribution of LOS for the specialties Vascular and 
Cardiology.  We observe increasing differences from about the median quantile for the specialties 
Rheumatology, Respiratory, and Hematology.  In these three specialties, for LOS below the 
median, coefficient estimates are mostly insignificant, indicating no difference in ALOS between 
obese and non-obese patients at lower levels of complexity.  For Respiratory and Rheumatology 
they are even slightly positive, indicating that obese stay longer at low levels of complexity, but 
shorter at higher levels of complexity in these two specialties.  For Neurosurgery, we observe 
significant differences for a few quantiles at the top of the distribution only, and no differences for 
the rest of the distribution.  This means that only among the very long staying and complex 
Neurosurgery patients the obese stay shorter than the non-obese.  The results for this specialty 
should be treated with caution, however, because it reported treating only 37 obese patients in 
the year and this small number may bias the results (see table 2).  For Urology and Nephrology, 
differences in ALOS are greatest for quantiles in the midranges of the distribution (between the 
40th and 75th quantiles), i.e. obese patient stay only shorter than non-obese at those medium 
ranges of LOS and complexity.  At higher quantiles, estimates for these two specialties are erratic 
and show no clear trend with one for the 90th quantile in Urology even being significantly positive, 
indicating a longer ALOS for the obese.  In Nephrology, estimates for the 80th, 85th and 90th 
quantiles are not trustworthy because standard errors are incredibly small.   
In summary, the negative pattern that obese patients stay -on average, conditional on 
explanatory factors, and at certain quantiles- at least one day less in hospital than non-obese 
patients can be observed for the specialties Vascular, Neurosurgery, Rheumatology,, 
Respiratory, and Cardiology.  Obese patients also stay shorter in the specialties Hematology, 
Urology, and Nephrology but the maximum differences are less than one day.  For nearly all of 
the above specialties, differences tend to be greater for patient groups with higher levels of 
medical complexity.  The results for these eight specialties contradict our hypothesis that obese 
patients stay longer in hospital and use more resources than non-obese patients with the same 
observable characteristics.  The implications of our results are that for these specialties, obese 
patients are less costly to treat than non-obese patients.   
5. Discussion 
Why do obese patients stay longer in some specialties, but shorter in others?  One explanation 
could be that there are differences in the way obese and non-obese patients with the same 
condition are managed once they are in hospital.  To explore this idea we estimate our model 
separately for medically and surgically managed patients, across all hospital specialties (for 
results see figures 18 and 19, and table 7).  The distinction between medical and surgical patients 
is derived from patient level ICD codes.  We find that for the medically managed patient group, 
obese patients stay on average longer than non-obese patients at nearly all quantiles, with peaks 
around the midranges of the distribution and the high end of the distribution.  Maximum difference 
at the 95th quantile is relatively small with 0.9 days.  The OLS coefficient is significantly positive.  
Interestingly, surgically managed obese patients have a shorter stay than non-obese patients.  
Differences are only present for quantiles above the median, and are nonexistent for lower 
quantiles.  The maximum difference is small, though, with only 0.4 days at the 90th quantile.  The 
OLS coefficient estimate is negative but insignificant.  
A discussion of the reasons for the observed positive and negative patterns is difficult without an 
in-depth analysis of potential differences in the way obese and non-obese patients are managed.  
Such an analysis is beyond the scope of this paper.  Here, we can only speculate that obese 
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patients may stay longer than non-obese when they are treated as a medical case because they 
are more complex.  However, they may have a shorter stay when they are treated as a surgical 
case because they are much more complex.  This may lead to them being transferred to another 
hospital, so that the hospital can shift the risk (and the cost) of treating complex obese surgical 
patients with a high likelihood of developing complications.  Another reason may be that obese 
patients stay in hospital is cut short because they are more likely to die from complications due to 
surgery than non-obese patients with the same medical condition.  Indeed we find that obese 
patients are transferred slightly more often and suffer more complications on average (see table 
1), but they are less likely to die.  However, conclusions derived from descriptive statistics such 
as this suffer from the fact that differences in medical complexity are not controlled for.  Further 
analysis of differences in the way obese and non-obese patients are managed is warranted.  It 
may be worthwhile to, for example, determine the probabilities of being treated as a medical 
case, being transferred or even to die, subject to whether being obese or not.  Our data would not 
be suited for such an analysis, because on specialty level, sample sizes would be too small to 
obtain any reliable results, especially for deaths among obese patients.   
6. Conclusions 
The analysis undertaken here makes an important contribution to measuring the impact of obesity 
on health care resources.  We show that obese patients stay longer in some specialties, but 
shorter in others.  This means it cannot simply be assumed that it is more costly to treat obese 
patients on average.  On the contrary, in some specialties they may be even less costly to treat.  
We demonstrate that looking at differences between obese and non-obese at average levels of 
medical complexity hides important information on differences in resource use among patient 
groups of varying medical complexity and length of stay and can lead to seriously misleading 
results.  Using quantile regression analysis, we generate information on differences in resource 
use across the whole distribution of length of stay and medical complexity.  Such information is 
crucial for policy makers and hospital managers to target resources across specialties.   
Future research is warranted.  It may focus on estimating the budgetary implications of results 
such as ours by, if possible (and beyond our data), attaching dollar values to the estimated 
differences in length of stay.  Research may also focus on differences in the way obese patients 
are managed in hospital and detailed investigation into the different stages at which resource use 
is most intense for obese patients.  This may help policy makers alleviate the financial impact of 
obesity and lead to efficiency gains for hospitals.  It may also help improve the quality of care for 
obese patients.   
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Table 1: Variables definitions and summary statistics 
Reported are means with standard deviations (in parentheses) for continuous variables, and 
percentages for binary variables. 
 
 Total 
sample
Non-obese 
inpatients 
Obese 
inpatients
  461,563 455,477 
(98.68%) 
6,086 
(1.32%) 
Dependent variable    
los Length of stay in days 4.93 (8.97) 4.91 (8.97) 6.62 (9.46) 
Explanatory variables    
Admission management    
nonelect 1 if patient is admitted as an emergency case, 
0 if not 
59.63 % 59.53 % 67.17 % 
elect 1 if patient is admitted from a waiting list, 0 if 
not 
28.97 % 28.95 % 29.90 % 
othadmtype 1 if patient is neither an elective nor 
emergency patient, 0 otherwise 
11.40 % 11.52 % 2.92 % 
transadmi1 1 if patient is admitted from another 
department, hospital or care centre, 0 if 
admitted from home 
6.09 % 6.07 % 7.71 % 
Discharge management    
homesep 1 if patient is discharged home or left against 
medical advice, 0 otherwise 
85.29 % 85.31 % 84.26 % 
transep 1 if patient is discharged to another 
department, hospital or care centre, 0 
otherwise 
12.66 % 12.64 % 13.92 % 
death 1 if patient dies in hospital, 0 otherwise 2.05 % 2.05 % 1.82 % 
Medical complexity    
w12wies Cost-weight (total weighted inlier equivalent 
separation including co-payments) 1.44 (2.34) 1.44 (2.34) 1.98 (2.85) 
numberdiag Total number of diagnoses and co-morbidities 4.52 (3.10) 4.48 (3.08) 7.72 (2.99) 
numberop Total number of procedures performed 2.45 (2.51) 2.45 (2.51) 3.01 (2.78) 
comp 1 if patient experienced a medical 
complication before or during episode, 0 
otherwise 
16.49 % 16.44 % 20.46 % 
Patient characteristics    
age Age at admission in years 53.48 53.41 58.47 
                                                  
1 Admission by transfer can be an elective, non-elective or another type of admission. 
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female 1 if patient is female, 0 if male, infant or 
intersex 
56.33 % 56.37 % 53.86 % 
private 1 if patient is admitted as a privately paying 
patient, 0 otherwise 
8.29 % 8.32 % 6.41 % 
seifa Socioeconomic index of relative advantage/ 
disadvantage 
988 (74.75) 988 (74.76) 976 (72.98) 
Hospital characteristics    
totsep Total separations of the hospital in the year 35,419 
(24,555) 
35,348 
(24,527) 
40,731 
(26,035) 
major 1 if major teaching hospital, 0 otherwise 71.74 % 71.72 % 73.61 % 
city 1 if big city hospital, 0 otherwise 13.45 % 13.45 % 13.52 % 
ruralmed 1 if medium sized hospital in regional centre, 
0 otherwise 
10.11 % 10.12 % 9.22 % 
ruralsmall 1 if small rural hospital, 0 otherwise 4.70 % 4.71 % 3.65 % 
 
 
Table 2: Obese patients by specialties 
 Percent 
Obese 
Patients 
Frequencies 
All Patients 
Frequencies 
Endocrinology 4.4 372 8,397
Cardiology 2.9 1,583 54,857 
Respiratory 1.9 802 42,407 
Nephrology 1.8 107 5,935 
Vascular 1.7 86 5,052 
Rheumatology 1.7 74 4,473 
General Medicine 1.4 517 36,437 
General Surgery 1.2 682 55,065 
Neurology 1.1 252 22,712 
Gynecology 1.1 131 11,908 
Urology 1.1 202 18,961 
Orthopaedics 1.0 397 39,178 
Haematology 1.0 100 10,278 
Gastroenterology 0.9 318 33,899 
Neurosurgery 0.7 37 5,599 
Plastics 0.6 67 11,513 
ENT 0.5 82 17,347 
Obstetrics 0.3 182 59,473 
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Table 3: OLS regression results on the whole sample 
      Source |       SS       df       MS              Number of obs =  461563 
-------------+------------------------------           F( 19,461543) =24090.94 
       Model |  18507584.2    19  974083.381           Prob > F      =  0.0000 
    Residual |  18661842.9461543  40.4335955           R-squared     =  0.4979 
-------------+------------------------------           Adj R-squared =  0.4979 
       Total |  37169427.2461562  80.5296519           Root MSE      =  6.3587 
 
------------------------------------------------------------------------------ 
         los |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       obese |  -.4432528   .0830581    -5.34   0.000     -.606044   -.2804615 
         age |  -.0328825   .0021111   -15.58   0.000    -.0370203   -.0287447 
        age2 |   .0005192   .0000199    26.03   0.000     .0004801    .0005583 
      female |   .3179608   .0199817    15.91   0.000     .2787972    .3571244 
    nonelect |   1.659798   .0227789    72.87   0.000     1.615152    1.704444 
  othadmtype |   1.299771   .0368011    35.32   0.000     1.227642      1.3719 
   transadmi |   .5190514   .0399814    12.98   0.000     .4406891    .5974137 
     private |  -.1197908   .0342449    -3.50   0.000    -.1869097   -.0526719 
       seifa |  -.0005178   .0001334    -3.88   0.000    -.0007793   -.0002564 
     w12wies |   2.379662   .0048312   492.56   0.000     2.370193    2.389131 
  numberdiag |   .2721024   .0039266    69.30   0.000     .2644064    .2797983 
    numberop |   .1880404   .0049733    37.81   0.000     .1782929    .1977879 
        comp |   .3004555   .0276291    10.87   0.000     .2463034    .3546076 
     transep |   .6221396   .0306083    20.33   0.000     .5621483     .682131 
       death |  -1.225421   .0687799   -17.82   0.000    -1.360227   -1.090614 
      totsep |  -.0000177   5.07e-07   -34.96   0.000    -.0000187   -.0000167 
       major |  -.0663907   .0310718    -2.14   0.033    -.1272904    -.005491 
    ruralmed |   .1252748   .0397072     3.15   0.002       .04745    .2030997 
  ruralsmall |   1.818782    .051869    35.06   0.000     1.717121    1.920444 
       _cons |  -.5572582   .1402436    -3.97   0.000    -.8321313    -.282385 
------------------------------------------------------------------------------ 
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Table 4: Quantile regression results on the 10th quantile, whole sample 
.1 Quantile regression                               Number of obs =    461563 
  Raw sum of deviations   362965 (about 1) 
  Min sum of deviations   340209                     Pseudo R2     =    0.0627 
 
------------------------------------------------------------------------------ 
         los |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       obese |   .0000685   .0107496     0.01   0.995    -.0210004    .0211374 
         age |   -.001803   .0002744    -6.57   0.000    -.0023408   -.0012651 
        age2 |   .0000362   2.60e-06    13.93   0.000     .0000311    .0000413 
      female |   .0491488   .0025804    19.05   0.000     .0440913    .0542063 
    nonelect |   .5178004   .0028796   179.82   0.000     .5121565    .5234442 
  othadmtype |   .7019123   .0047048   149.19   0.000     .6926911    .7111335 
   transadmi |   .0768514    .005219    14.73   0.000     .0666222    .0870806 
     private |   .0141874   .0044278     3.20   0.001     .0055091    .0228658 
       seifa |  -.0001594   .0000175    -9.09   0.000    -.0001938    -.000125 
     w12wies |   .6706648   .0005491  1221.30   0.000     .6695885    .6717411 
  numberdiag |   .0240526   .0005105    47.11   0.000      .023052    .0250533 
    numberop |   .0868354    .000643   135.04   0.000     .0855751    .0880957 
        comp |   .1146201   .0036959    31.01   0.000     .1073762    .1218641 
     transep |  -.0750283    .004071   -18.43   0.000    -.0830073   -.0670494 
       death |  -.3402695   .0088737   -38.35   0.000    -.3576617   -.3228773 
      totsep |  -2.02e-06   6.46e-08   -31.32   0.000    -2.15e-06   -1.90e-06 
       major |   .0149594    .004026     3.72   0.000     .0070685    .0228503 
    ruralmed |   .0439188   .0051424     8.54   0.000     .0338398    .0539978 
  ruralsmall |   .1518471    .006766    22.44   0.000      .138586    .1651082 
       _cons |   .0626135   .0183434     3.41   0.001      .026661    .0985659 
------------------------------------------------------------------------------ 
 
Table 5: Quantile regression results on the 50th quantile, whole sample 
Median regression                                    Number of obs =    461563 
  Raw sum of deviations  1639355 (about 3) 
  Min sum of deviations  1191026                     Pseudo R2     =    0.2735 
 
------------------------------------------------------------------------------ 
         los |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       obese |  -.0017679   .0230902    -0.08   0.939     -.047024    .0434882 
         age |  -.0167716   .0005869   -28.57   0.000    -.0179219   -.0156212 
        age2 |    .000266   5.55e-06    47.96   0.000     .0002551    .0002768 
      female |   .1479412   .0055553    26.63   0.000      .137053    .1588294 
    nonelect |   1.286052    .006333   203.07   0.000     1.273639    1.298464 
  othadmtype |   1.418474   .0102312   138.64   0.000     1.398421    1.438527 
   transadmi |   .8020076   .0111156    72.15   0.000     .7802215    .8237937 
     private |    .179319   .0095206    18.83   0.000     .1606589    .1979791 
       seifa |  -.0004369   .0000371   -11.78   0.000    -.0005095   -.0003642 
     w12wies |   1.351366   .0013431  1006.12   0.000     1.348734    1.353999 
  numberdiag |   .1343683   .0010916   123.09   0.000     .1322287    .1365079 
    numberop |   .3735434   .0013827   270.16   0.000     .3708334    .3762534 
        comp |   .5970041   .0076814    77.72   0.000     .5819487    .6120595 
     transep |   .1447832   .0085097    17.01   0.000     .1281045    .1614619 
       death |  -.3849853   .0191215   -20.13   0.000    -.4224628   -.3475077 
      totsep |  -3.71e-06   1.41e-07   -26.37   0.000    -3.99e-06   -3.44e-06 
       major |  -.1568498   .0086385   -18.16   0.000    -.1737809   -.1399187 
    ruralmed |   .1518687   .0110393    13.76   0.000     .1302319    .1735054 
  ruralsmall |    1.04784   .0144204    72.66   0.000     1.019576    1.076103 
       _cons |  -.3109414   .0389903    -7.97   0.000    -.3873613   -.2345215 
Table 6: Quantile regression results on the 90th quantile, whole sample 
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.9 Quantile regression                               Number of obs =    461563 
  Raw sum of deviations  1517523 (about 11) 
  Min sum of deviations 828234.6                     Pseudo R2     =    0.4542 
 
------------------------------------------------------------------------------ 
         los |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
       obese |   .2018728   .0849429     2.38   0.017     .0353874    .3683581 
         age |  -.0214345   .0021553    -9.94   0.000    -.0256589   -.0172101 
        age2 |   .0004821   .0000204    23.62   0.000     .0004421    .0005221 
      female |   .2001051   .0204387     9.79   0.000     .1600458    .2401643 
    nonelect |   1.739039   .0248285    70.04   0.000     1.690376    1.787703 
  othadmtype |   .5232556   .0382338    13.69   0.000     .4483185    .5981927 
   transadmi |   1.935422   .0405322    47.75   0.000      1.85598    2.014864 
     private |  -.0359601    .035034    -1.03   0.305    -.1046256    .0327055 
       seifa |  -.0010283   .0001353    -7.60   0.000    -.0012934   -.0007632 
     w12wies |   4.851081   .0060659   799.72   0.000     4.839192     4.86297 
  numberdiag |    .288854   .0040367    71.56   0.000     .2809422    .2967657 
    numberop |    .393806   .0057989    67.91   0.000     .3824403    .4051717 
        comp |   1.096721   .0279632    39.22   0.000     1.041914    1.151528 
     transep |   1.572372   .0297835    52.79   0.000     1.513998    1.630747 
       death |    2.31425   .0700748    33.03   0.000     2.176905    2.451594 
      totsep |  -9.65e-06   5.10e-07   -18.94   0.000    -.0000107   -8.66e-06 
       major |  -.2791145   .0315785    -8.84   0.000    -.3410075   -.2172215 
    ruralmed |   .1461406   .0403702     3.62   0.000     .0670164    .2252649 
  ruralsmall |   2.459224    .052231    47.08   0.000     2.356853    2.561595 
       _cons |    .066759   .1418455     0.47   0.638    -.2112539    .3447718 
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Table 7: Results on differences in ALOS between obese and non-obese inpatients, by 
specialty  
 Specialty 
Maximum difference 
between obese and 
non-obese patients, 
in days (SE in 
parenthesis)1 
Percentile of the 
distribution of LOS 
at which maximum 
difference is 
observed 
Positive Pattern 
(obese patients 
stay longer than 
non-obese 
patients) 
General Medicine 3.8 (0.04) 95th 
Plastic Surgery 1.9 (0.14) 80th 
Obstetrics 1.4 (0.20) 95th 
ENT 1.1 (0.05) 80th 
Orthopedics 1.0 (0.13) 90th 
Gynecology 0.9 (0.13) 95th 
Neurology 0.4 (0.01) 95th 
Endocrinology 0.4 (0.07) 75th 
General Surgery 0.2 (0.03) 75th 
Medically managed 
patients 
(across all specialties) 
0.9 (0.00) 95th 
Negative Pattern  
(obese patients 
stay shorter than 
non-obese 
patients) 
Vascular -2.4 (0.33) 95th 
Neurosurgery -1.7 (0.37) 95th 
Rheumatology -1.5 (0.16) 95th 
Respiratory -1.2 (0.43) 95th 
Cardiology -1.1 (0.17) 95th 
Hematology -0.6 (0.00) 95th 
Urology -0.5 (0.01) 95th 
Nephrology -0.4 (0.04) 75th 
Surgically managed 
patients  
(across all specialties) 
-0.4 (0.03) 90th 
1 only statistically significant coefficients are reported. 
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Figure 1: General Medicine – differences in LOS between obese and non-obese patients 
(upper and lower bounds of the 95% confidence intervals are displayed for the OLS coefficient, but not 
the QR coefficients because interval bands are too small for all quantiles) 
 
 
 
Figure 2: Plastic Surgery – differences in LOS between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
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Figure 3: Obstetrics – differences in LOS between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
 
 
 
Figure 4: E NT – differences in LOS between obese and non-obese patients 
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Figure 5: Orthopedics – differences in LOS between obese and non-obese patients 
 
 
 
 
Figure 6: Gynecology – differences in LOS between obese and non-obese patients 
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Figure 7: Neurology – differences in LOS between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
 
 
 
Figure 8: Endocrinology – differences in LOS between obese and non-obese patients 
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Figure 9: General Surgery – differences in LOS between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
 
 
 
Figure 10: Vascular – differences in LOS between obese and non-obese patients 
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Figure 11: Neurosurgery – differences in LOS between obese and non-obese patients 
 
 
 
 
Figure 12: Rheumatology – differences in LOS between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
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Figure 13: Respiratory – differences in LOS between obese and non-obese patients 
 
 
 
 
Figure 14: Cardiology – differences in LOS between obese and non-obese patients 
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Figure 15: Hematology – differences in LOS between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
 
 
 
Figure 16: Urology – differences in LOS between obese and non-obese patients 
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Figure 17: Nephrology – differences in LOS between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
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Figure 18: Medically managed patients (across all specialties) – differences in LOS 
between obese and non-obese patients 
(for some quantiles, CI bands are so small that they are not displayed) 
 
 
Figure 19: Surgically managed patients (across all specialties) – differences in LOS 
between obese and non-obese patients 
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